Achieve Life Sciences (ACHV) Debt Ratio (2016 - 2025)
Achieve Life Sciences (ACHV) recorded quarterly Debt Ratio of 0.09 in Q4 2025, up 283.1% on a QoQ basis from 0.02 in Q3 2025.
Achieve Life Sciences (ACHV) Debt Ratio (2016 - 2025) Analysis & Trends
Achieve Life Sciences has disclosed Debt Ratio across 5 years of filings, most recently posting 0.09 for Q4 2025.
- Quarterly Debt Ratio changed N/A year-over-year to 0.09 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.09 (changed N/A YoY) and the FY2025 annual result came in at 0.09, changed N/A from the prior year.
- Debt Ratio advanced to 0.09 in Q4 2025, from 0.02 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.79 in Q1 2023 and troughed at 0.02 in Q2 2025.
- A 4-year average of 0.21 and a median of 0.09 in 2025 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2023 — Debt Ratio sank 94.92% — and 2024, when it plunged 68.9%.
- Tracing ACHV's Debt Ratio over 4 years: stood at 0.54 in 2022, then slumped by 94.92% to 0.03 in 2023, then surged by 398.52% to 0.14 in 2024, then tumbled by 34.77% to 0.09 in 2025.
- Business Quant data shows ACHV's Debt Ratio at 0.09 in Q4 2025, 0.02 in Q3 2025, and 0.02 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.18 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.04 |
| Jun 30, 2024 | 0.14 |
| Mar 31, 2024 | 0.24 |
| Dec 31, 2023 | 0.03 |
| Mar 31, 2023 | 0.79 |
| Dec 31, 2022 | 0.54 |
| Dec 31, 2016 | 0.22 |